Journal of Nuclear Medicine June 2026, jnumed.125.271460; DOI: https://doi.org/10.2967/jnumed.125.271460 ...

Journal of Nuclear Medicine May 2026, jnumed.126.272619; DOI: https://doi.org/10.2967/jnumed.126.272619 ...

Journal of Nuclear Medicine May 2026, jnumed.125.271093; DOI: https://doi.org/10.2967/jnumed.125.271093 ...

Journal of Nuclear Medicine May 2026, jnumed.125.271707; DOI: https://doi.org/10.2967/jnumed.125.271707 ...

Journal of Nuclear Medicine April 2026, jnumed.125.271933; DOI: https://doi.org/10.2967/jnumed.125.271933 ...

Journal of Nuclear Medicine April 2026, jnumed.125.271565; DOI: https://doi.org/10.2967/jnumed.125.271565 ...

Journal of Nuclear Medicine March 2026, jnumed.125.271031; DOI: https://doi.org/10.2967/jnumed.125.271031 ...

Genomic alterations are common in metastatic castration-resistant prostate cancer (mCRPC), but limited data exist on the response to 177Lu-PSMA-617 (LuPSMA) in patients with these aberrations. We ...

Limbic-predominant age-related transactive response DNA-binding protein 43 kDa encephalopathy (LATE) is emerging as a prevalent neurodegenerative disorder in aging populations, mimicking the clinical ...

Journal of Nuclear Medicine January 2026, jnumed.125.271317; DOI: https://doi.org/10.2967/jnumed.125.271317 ...

Journal of Nuclear Medicine October 2025, jnumed.125.270239; DOI: https://doi.org/10.2967/jnumed.125.270239 ...

Journal of Nuclear Medicine October 2025, jnumed.124.269188; DOI: https://doi.org/10.2967/jnumed.124.269188 ...